790
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology, Genetics & Genomic

A novel variant of SFTPA2 in a Han Chinese family with interstitial lung disease and lung cancer

, , &
Pages 840-845 | Received 16 Oct 2020, Accepted 06 Aug 2021, Published online: 13 Sep 2021

References

  • Ali M, Umstead TM, Haque R, Mikerov AN, Freeman WM, Floros J, Phelps DS. 2010. Differences in the BAL proteome after Klebsiella pneumoniae infection in wild type and SP-A-/- mice. Proteome Sci. 17(8):34.
  • Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. 2014. Interstitial lung disease. Eur Respir Rev. 1(23):40–54.
  • Azadeh N, Moua T, Baqir M, Ryu JH. 2018. Treatment of acute exacerbations of interstitial lung disease. Expert Rev Respir Med. 12:309–313.
  • Borie R, Danel C, Debray MP, Taille C, Dombret MC, Aubier M, Epaud R, Crestani B. 2011. Pulmonary alveolar proteinosis. Eur Respir Rev. 20:98–107.
  • Coghlan MA, Shifren A, Huang HJ, Russell TD, Mitra RD, Zhang Q, Wegner DJ, Cole FS, Hamvas A. 2014. Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations. BMJ Open Respir Res. 1:e000057.
  • Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park JS, Poonyagariyagorn HK, Wuyts W, et al. 2018. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 31:27.
  • Devine MS, Garcia CK. 2012. Genetic interstitial lung disease. Clin Chest Med. 33:95–110.
  • du Bois RM. 2002. The genetic predisposition to interstitial lung disease: functional relevance. Chest. 121:14S–20S.
  • Guillot L, Nathan N, Tabary O, Thouvenin G, Le Rouzic P, Corvol H, Amselem S, Clement A. 2013. Alveolar epithelial cells: master regulators of lung homeostasis. Int J Biochem Cell Biol. 45:2568–2573.
  • Heinrich S, Hartl D, Griese M. 2006. Surfactant protein A–from genes to human lung diseases. Curr Med Chem. 13:3239–3252.
  • Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. 2006. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol. 43:1293–1315.
  • Korfhagen TR, LeVine AM, Whitsett JA. 1998. Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta. 19(1408):296–302.
  • Legendre M, Butt A, Borie R, Debray MP, Bouvry D, Filhol-Blin E, Desroziers T, Nau V, Copin B, Dastot-Le Moal F, et al. 2020. Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer. Eur Respir J. 56(6):2002806.
  • Liu L, Luo H. 2018. Whole-Exome sequencing identified a novel compound heterozygous mutation of LRRC6 in a Chinese primary ciliary dyskinesia patient. Biomed Res Int. 2018:1854269.
  • Liu L, Qin J, Guo T, Chen P, Ouyang R, Peng H, Luo H. 2020. Identification and functional characterization of a novel surfactant protein A2 mutation (p.N207Y) in a Chinese family with idiopathic pulmonary fibrosis. Mol Genet Genomic Med. 8:e1393.
  • Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, Holmskov U. 2003. Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 29:591–597.
  • Maitra M, Wang Y, Gerard RD, Mendelson CR, Garcia CK. 2010. Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress. J Biol Chem. 16(285):22103–22113.
  • McCormack FX, Whitsett JA. 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest. 109:707–712.
  • Mikerov AN, Haque R, Gan X, Guo X, Phelps DS, Floros J. 2008. Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir Res. 4(9):77.
  • Newton CA, Molyneaux PL, Oldham JM. 2018. Clinical Genetics in interstitial lung disease. Front Med (Lausanne). 5:116.
  • Phelps DS, Umstead TM, Quintero OA, Yengo CM, Floros J. 2011. In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement. Proteome Sci. 28(9):67.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–424.
  • Song Y, Fang G, Shen H, Li H, Yang W, Pan B, Huang G, Lin G, Ma L, Willard B, et al. 2012. Human surfactant protein A2 gene mutations impair dimmer/trimer assembly leading to deficiency in protein sialylation and secretion. PLoS One. 7:e46559.
  • van Moorsel CH, Ten Klooster L, van Oosterhout MF, de Jong PA, Adams H, van Es H W, Ruven HJ, van der Vis JJ, Grutters JC. 2015. SFTPA2 mutations in familial and sporadic idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 15(192):1249–1252.
  • Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK. 2009. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet. 84:52–59.
  • Wolters PJ, Collard HR, Jones KD. 2014. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 9:157–179.
  • Yang HY, Li H, Wang YG, Xu CY, Zhao YL, Ma XG, Li XW, Chen H. 2014. Correlation analysis between single nucleotide polymorphisms of pulmonary surfactant protein A gene and pulmonary tuberculosis in the Han population in China. Int J Infect Dis. 26:31–36.